SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer
PANGYO, South Korea & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Apr 17, 2019--SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and cance…
